Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard G. Vincent currently holds 2,000 shares of Oncternal Therapeutics, Inc. (ONCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard G. Vincent has been a net buyer of ONCT stock. They have purchased $37.8K and sold $0 worth of shares.
Richard G. Vincent's most recent insider trade was on Sep 17, 2024, when they sold 2,000 shares at $0.00 per share.
Richard G. Vincent serves as Executive at Oncternal Therapeutics, Inc. (ONCT). They have executed 19 insider transactions totaling $37.8K over their tenure at the company.
Richard G. Vincent holds the position of Executive at Oncternal Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Richard G. Vincent has shown a buying trading pattern, with $37.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Richard G. Vincent was on Apr 13, 2023, when they purchased $9.0K worth of ONCT shares. This transaction involved 30,000 shares at $0.30 per share.
Richard G. Vincent currently owns 2,000 shares of Oncternal Therapeutics, Inc. (ONCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard G. Vincent's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard G. Vincent has 19 Form 4 filings on record as an insider at Oncternal Therapeutics, Inc..
Set alerts for Richard G. Vincent and 40,000+ other insiders.